Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
Holding KIDS?
Track your performance easily
KIDS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$22.41 - $36.23
Previous Close$24.32
Volume181.30K
Average Volume (3M)161.88K
Market Cap
$588.93M
Enterprise Value$561.10M
Total Cash (Recent Filing)$76.06M
Total Debt (Recent Filing)$48.23M
Price to Earnings (P/E)―
Beta1.31
Next Earnings
Mar 05, 2025EPS Estimate
-$0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.24
Shares Outstanding24,215,936
10 Day Avg. Volume254,617
30 Day Avg. Volume161,875
Standard Deviation0.12
R-Squared0.26
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)1.59
Price to Sales (P/S)2.93
Price to Cash Flow (P/CF)-13.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.96
Enterprise Value/Gross Profit5.04
Enterprise Value/Ebitda-38.16
Forecast
1Y Price Target
$44.00Price Target Upside72.41% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
OrthoPediatrics News
PremiumCompany Announcements
OrthoPediatrics Innovates in Pediatric Orthopedics Market
PremiumCompany Announcements
OrthoPediatrics Corp. Posts Strong Q3 Results
PremiumCompany Announcements
OrthoPediatrics Showcases Growth and Outlook in Investor PresentationsBulls Say, Bears Say
Bulls Say
EarningsQuarterly results came in ahead of consensus, and FY24 guidance was raised on the top line.
Growth PotentialThere is a promising pathway for KIDS to re-emerge as a premium growth small cap franchise within MedTech.
Market PositionKIDS is considered a differentiated participant in the largely underserved pediatric-orthopedic industry, with potential to achieve further penetration in its base markets and enter complementary, attractive orthopedic arenas.
Bears Say
Financial PerformanceGross margin was down 400 bps Y/Y driven by increased 7D unit placements that carry a lower gross margin.
Operational ChallengesCOVID-19 and its lingering headwinds, along with RSV, have negatively impacted the business, leading to procedural deferrals and staffing issues.
Product Mix And CostGross margin for the quarter was 73.4%, down ~400 bps y/y, demonstrating shifts in product mix and unfavorable purchase price variance compared to the prior-year period.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
KIDS FAQ
What was OrthoPediatrics Corp’s price range in the past 12 months?
OrthoPediatrics Corp lowest stock price was $22.41 and its highest was $36.23 in the past 12 months.
What is OrthoPediatrics Corp’s market cap?
Currently, no data Available
When is OrthoPediatrics Corp’s upcoming earnings report date?
OrthoPediatrics Corp’s upcoming earnings report date is Mar 05, 2025 which is in 104 days.
How were OrthoPediatrics Corp’s earnings last quarter?
OrthoPediatrics Corp released its earnings results on Nov 06, 2024. The company reported -$0.18 earnings per share for the quarter, beating the consensus estimate of -$0.227 by $0.047.
Is OrthoPediatrics Corp overvalued?
According to Wall Street analysts OrthoPediatrics Corp’s price is currently Undervalued.
Does OrthoPediatrics Corp pay dividends?
OrthoPediatrics Corp does not currently pay dividends.
What is OrthoPediatrics Corp’s EPS estimate?
OrthoPediatrics Corp’s EPS estimate is -$0.3.
How many shares outstanding does OrthoPediatrics Corp have?
OrthoPediatrics Corp has 24,215,937 shares outstanding.
What happened to OrthoPediatrics Corp’s price movement after its last earnings report?
OrthoPediatrics Corp reported an EPS of -$0.18 in its last earnings report, beating expectations of -$0.227. Following the earnings report the stock price went down -11.179%.
Which hedge fund is a major shareholder of OrthoPediatrics Corp?
Among the largest hedge funds holding OrthoPediatrics Corp’s share is Royce & Associates LLC. It holds OrthoPediatrics Corp’s shares valued at 358K.
---
OrthoPediatrics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$44.00 (72.41% Upside)
$44.00 (72.41% Upside)
Insider Transactions
Sold Shares
Worth $293.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.07%
12-Months-Change
Fundamentals
Return on Equity
-7.63%
Trailing 12-Months
Asset Growth
13.15%
Trailing 12-Months
Company Description
OrthoPediatrics Corp
OrthoPediatrics Corp. is a medical device company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. Its products includes PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, RESPONSE Spine, Bandloc and Pediguard. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.
---
KIDS Earnings Call
Q3 2024
0:00 / 0:00
---
KIDS Stock 12 Month Forecast
Average Price Target
$44.00
▲(72.41% Upside)
Technical Analysis
Best Analysts Covering KIDS
1 Year
1 Year Success Rate
7/28 ratings generated profit
1 Year Average Return
-12.10%
reiterated a buy rating 14 days ago
Copying Michael Matson's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -12.10% per trade.
---